
Loading, please wait...

Loading, please wait...

Chronic pelvic pain remains the most debilitating symptom for women suffering from endometriosis. While local inflammation drives initial discomfort, many patients continue to experience pain even after surgical removal of lesions. This persistence suggests that central sensitization in endometriosis plays a pivotal role in the transition from nociceptive to nociplastic pain. Central sensitization occurs when the central nervous system stays in a state of high reactivity, amplifying even mild sensory inputs into significant pain. Therefore, understanding this mechanism is essential for clinicians who manage treatment-resistant cases.
A recent single-center, cross-sectional study conducted in Udine investigated the prevalence of this condition among 142 patients with endometriosis or adenomyosis. The researchers utilized the Central Sensitization Inventory (CSI), a validated tool, to identify those with systemic sensitivity. Remarkably, the study found that the prevalence of central sensitization in endometriosis was 52.1%. This high percentage highlights why conventional hormonal and surgical therapies often fail to provide complete relief. Furthermore, the analysis revealed that specific clinical symptoms, namely dyspareunia and vulvodynia, were significantly associated with high CSI scores. Consequently, patients presenting with these symptoms may require a more specialized pain management approach.
Identifying central sensitization early can prevent years of unsuccessful treatments and improve patient quality of life. Clinicians should integrate screening tools like the CSI into routine gynecological evaluations. When scores exceed the threshold of 40, the focus of care must shift. Instead of solely targeting peripheral lesions, doctors should consider a multidisciplinary strategy. This approach often includes neuromodulators, pelvic floor physiotherapy, and psychological support. Moreover, educating patients about pain neuroscience can reduce anxiety and empower them in their recovery journey. Ultimately, addressing the central nervous system's role is the key to managing complex pelvic pain effectively.
Research indicates that approximately 52.1% of women with a diagnosis of endometriosis or adenomyosis exhibit signs of central sensitization. This high prevalence suggests it is a major factor in chronic pain presentations.
In the study, dyspareunia and vulvodynia were the primary clinical characteristics significantly associated with central sensitization. If these symptoms persist despite standard care, central mechanisms are likely involved.
Surgery may not be sufficient to resolve central sensitization because the central nervous system has already been programmed to maintain a state of hypersensitivity. In these cases, a multimodal approach including pain management specialists is recommended.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Biasioli A et al. Central sensitization in women with endometriosis: a cross-sectional study. BMC Womens Health. 2026 Feb 17. doi: 10.1186/s12905-026-04348-8. PMID: 41703551.
Mechsner S. Algorithm for pain management in endometriosis. EndoNews. 2022. Available at: https://www.endonews.com/algorithm-for-pain-management-in-endometriosis.
Evans S, et al. Peripheral, Central, and Cross Sensitization in Endometriosis-Associated Pain and Comorbid Pain Syndromes. Frontiers in Network Physiology. 2022;2:1010323.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A cross-sectional study finds that 52.1% of women with endometriosis suffer from central sensitization, primarily associated with dyspareunia and vulvodynia...
8 months ago

Following Nigeria's first recorded Ebola case linked to regional travel, the Africa CDC has convened an emergency ministerial summit. This alert underscores critical clinical priorities for healthcare professionals, including differentiating early viral infection from malaria, implementing barrier nursing, and triage.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today